LBA3: Sites of relapse and subsequent therapy in the BR.31 phase III study of durvalumab vs placebo in resected stage IB-IIIA NSCLC
V. Westeel, Glenwood Goss, Gail Darling, K. Nakagawa et autres
fr, ca, jp, es, it, au, kr, cn, nl, pl (code pays fourni par la source)